loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2014_291___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Cambrex Corporation

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INTERMEDIATES

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 CAMBREX KARLSKOGA AB Karlskoga SE (1)

    filter

    01 Rivastigmine (1)

    filter

    01 U.S.A (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    CAMBREX KARLSKOGA AB Karlskoga SE

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Rivastigmine

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2014-291 - Rev 01
    Valid
    Chemical
    2023-05-30
    2629
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2014-291 - Rev 01 of Cambrex Karlskoga Ab Karlskoga Se

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2014-291 - Rev 01 of Cambrex Karlskoga Ab Karlskoga Se 1

    20

    Cambrex Karlskoga Ab Karlskoga Se, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for Cambrex is an innovative life sciences company with a refreshingly human approach.

    One of their significant offerings is Rivastigmine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2014-291 - Rev 01

    This Chemical Type CEP, issued on May 30, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2629 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY